Abstract Stroke is pathologically associated with oxidative stress, protein damage, and neuronal loss. We previously reported that overexpression of a ubiquitin-like protein, ubiquilin-1 (Ubqln), protects neurons against ischemiacaused brain injury, while knockout of the gene exacerbates cerebral ischemia-caused neuronal damage and delays functional recovery. Although these observations indicate that Ubqln is a potential therapeutic target, transgenic manipulation-caused overexpression of Ubqln occurs before the event of ischemic stroke, and it remains unknown whether delayed Ubqln overexpression in post-ischemic brains within a clinically relevant time frame is still beneficial. To address this question, we generated lentiviruses (LVs) either overexpressing or knocking down mouse Ubqln, and treated post-ischemic stroke mice 6 h following the middle cerebral artery occlusion with the LVs before animal behaviors were evaluated at day 1, 3, 5, and 7. Our data indicate that postischemic overexpression of Ubqln significantly promoted functional recovery, whereas post-ischemic downregulation of Ubqln expression delays functional recovery. To further understand the mechanisms underlying how Ubqln functions, we also isolated protein aggregates from the brains of wild-type mice or the mice overexpressing Ubqln following ischemia/reperfusion. Western blot analysis indicates that overexpression of Ubqln significantly reduced the accumulation of protein aggregates. These observations not only suggest that Ubqln is a useful candidate for therapeutic intervention for ischemic stroke but also highlight the significance of proteostasis in functional recovery following stroke.
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Introduction
Maintaining intracellular protein homeostasis (proteostasis) is critical for cell survival and normal functions (Chen et al. 2012 ).
In the condition of ischemic stroke, however, oxidative stress and protein aggregates occur (Ge et al. 2007; Huang et al. 2012) , which impair proteostasis. Our previous studies have revealed that ubiquilin-1 (Ubqln) interacts with misfolded proteins and selectively enhances their degradation (Wang and Monteiro 2007) . Our recent results suggest that Ubqln is a potential therapeutic target for ischemic stroke, as overexpression (OE) of Ubqln protects cells against oxidative stress and ischemia/ reperfusion (I/R)-caused brain injury, but knockout (KO) of the gene shows the opposite results (Liu et al. 2014b) . In these studies, however, alteration of Ubqln expression occurs prior to ischemic insults. It remains unknown whether delayed manipulation of the Ubqln protein level within a clinically relevant time window has a similar effect as what we observed from the transgenic or KO ischemic stroke mice. To address this question, we have generated lentiviruses (LVs) that overexpress either mouse Ubqln or small hairpin (sh) RNAs and tested the effect of OE or knockdown of Ubqln on functional recovery in post-ischemic mice.
Materials and Methods

Animals
All animal maintenance and experimental procedures were in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the University of South Dakota.
Middle Cerebral Artery Occlusion (MCAO) and Intracerebral Injection of LVs
Adult male mice with the C57BL/6 background (2-3 months, 22-30 g, Envigo, Indianapolis, IN, USA) were subjected to 90-min MCAO as previously described (Lu and Wang 2012) . After 6 h reperfusion, the mice were intrastriatally injected with 2 ll of concentrated LVs overexpressing mouse Ubqln, the enhanced green fluorescent protein (GFP), Ubqln shRNAs, or scramble shRNAs into the ipsilateral brain using a previously described method (Wang et al. 2004 ). Mice were then allowed to survive for 7 days and animal behaviors were tested at day 1, 3, 5, and 7. 
Animal Behavior Tests
We used a previously described modified neurologic severity score (mNSS) to assess neurological deficits after I/R (Chen et al. 2005) . With this system, animal neurologic function was graded on a scale of 0-14 (normal score 0; maximal deficit score 14) including motor, reflex, and balance tests. One score point is given to a mouse for its failure in performing a specific task or for its lack of a tested reflex; thus, the score received by an animal reflects the severity of the brain injury.
Preparation and Verification of Lentiviruses
To generate the LV-Ublqn, we replaced the cDNA encoding GFP in the pLenti-CMV-GFP plasmid (Campeau et al. 2009 ) with a full-length mouse Ubqln cDNA sequence (Liu et al. 2014b ). The four different mouse LV-Ubqln-shRNAs and the scramble control were purchased from OriGene (Rockville, MD, USA). LV packing and concentration were performed according to previously described methods (Stewart et al. 2003; Park et al. 2008) . To verify the LV gene expression, HeLa or mouse striatal cells (CH00097, Coriell, Camden, NJ, USA) were transduced with LVs in the presence of polybrene (8 lg/ml) for different times depending on specific experiments, the cells were then subjected to western analysis of either Ubqln or GFP expression using a specific antibody.
Isolation of Triton-X100 Insoluble Protein Aggregates
Isolation of Triton-X100-insoluble protein aggregates was based on a previously described method (Ge et al. 2007 ).
Western Blot Analysis
Cell lysates or isolated protein aggregates were sonicated and then separated in 10 or 12% SDS PAGE before being transferred onto a nitrocellulose membrane for immunoblotting analysis as previously described (Dong et al. 2012) . The primary and secondary antibodies were previously described (Liu et al. 2014a ).
Statistical Analysis
Two group comparisons were statistically analyzed by the two-tailed Student's t test. p \ 0.05 was regarded as statistically significant.
Results and Discussion
LVs are a class of retrovirus that are highly efficient in infecting both dividing and non-dividing cells, making the recombinant lentiviral vectors an ideal tool for manipulation of gene expression in post-mitotic neurons (Deglon and Aebischer 2002) . To test whether upregulation of Ubqln in the post-ischemic mouse brain exerts a beneficial effect on animal functional recovery, we generated pseudo-LVs expressing either Ubqln or GFP, and validated the LVs in HeLa cells. Our results indicate that 24 h after transduction, the cells showed remarkable OE of Ubqln in a dose-dependent manner (Fig. 1a) . To further determine the temporal expression pattern of the LV vector in neurons following transduction, we transduced LV-GFP into cultured mouse striatal cells before the cells were collected every 2 h for assessing GFP levels. This allowed us to conveniently determine how long the LV gene took to express, as the striatal cells did not express endogenous GFP. As shown in Fig. 1b , expression of LV-GFP in the mouse neurons was detectible at 2 h but reached a peak at 12 h following transduction. These data suggest that the LV gene shows rapid expression following transduction. We then tested whether delivering the LVs into the I/Rinjured brains alters animal functional outcomes. Accordingly, we performed MCAO to the animals and after 6 h following reperfusion, mice were intrastriatally injected with concentrated LVs either overexpressing Ubqln or GFP into the injury side (Fig. 1c) . Treatment of the stroke mice with LV-Ubqln significantly enhanced the animal functional recovery compared to the control LV-GFP treatment (Fig. 1d) . To confirm above observation and further define whether appropriate Ubqln expression is required for neuroprotection after stroke occurs, we also generated lentiviral particles expressing Ubqln shRNAs to knockdown Ubqln expression or scramble RNAs to function as a control, and then verified these LVs in cultured striatal cells. As shown in Fig. 2a , transduction of the LV-Ubqln-shRNAs reduced Ubqln protein levels compared to the scramble shRNA transductions, thus indicating that the LVs can effectively downregulate Ubqln expression in neuronal cells. We then treated ischemic stroke mice with either lentiviral Ubqln shRNAs or scramble shRNAs by intrastriatally injecting them into the injured brain sides. Our results showed that knockdown of Ubqln in mice after ischemic stroke exacerbated animal neurological deficits (Fig. 2b) , as reflected by increased mNSSs compared to the scramble treatment. These data suggest that downregulation of Ubqln expression in ischemic stroke mice delays functional recovery.
Ischemic stroke causes oxidative stress, protein damages, and accumulation of ubiquitinated protein aggregates (Ge et al. 2007 ). To further understand how Ubqln functions in the condition of ischemic stroke, we isolated protein aggregates from the wild-type or Ubqln transgenic (Tg) mouse brains 24 h following I/R, since the Tg mice exhibited significant tolerance to I/R-caused brain injury and marked Ubqln overexpression in different brain regions (Liu et al. 2014a) . Western blot analysis of the protein aggregates indicated that, compared to the sham procedure, I/R induced pronounced accumulation of ubiquitinated protein aggregates (Fig. 3a, b) . In contrast, the transgenic mouse brains showed significantly reduced protein aggregates (Fig. 3a, b) . Thus, OE of Ubqln attenuates damaged protein accumulation.
Cerebral I/R is associated with oxidative stress and causes accumulation of protein aggregates in the brain cells (Ge et al. 2007; Huang et al. 2012) . To develop effective treatment for ischemic stroke, it is important to determine whether enhanced removal of these damaged proteins is beneficial. Here we demonstrated that post-ischemic OE of Ubqln, a protein that selectively enhances degradation of misfolded proteins (Wang and Monteiro 2007) , enhances animal functional recovery, whereas knockdown of Ubqln delays functional recovery following I/R. More importantly, OE of Ubqln reduces accumulation of protein aggregates in I/R-damaged brains. These data highlight the significance of protein homeostasis in neuroprotection following I/R. 
